Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001206774-22-000833
Filing Date
2022-03-24
Accepted
2022-03-24 16:04:35
Documents
10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS gild3988061-defa14a.htm DEFA14A 43847
2 GRAPHIC gild3988061-defa14ax1x1.jpg GRAPHIC 12724
3 GRAPHIC gild3988061-defa14ax1x1a.jpg GRAPHIC 6466
4 GRAPHIC gild3988061-defa14ax1x2.jpg GRAPHIC 28028
5 GRAPHIC gild3988061-defa14ax1x3.jpg GRAPHIC 4969
6 GRAPHIC gild3988061-defa14ax1x4.jpg GRAPHIC 4371
7 GRAPHIC gild3988061-defa14ax1x5.jpg GRAPHIC 4234
8 GRAPHIC gild3988061-defa14ax1x6.jpg GRAPHIC 11994
9 GRAPHIC gild3988061-defa14ax2x1.jpg GRAPHIC 1092
10 GRAPHIC gild3988061-defa14ax2x1aa.jpg GRAPHIC 1083
  Complete submission text file 0001206774-22-000833.txt   149416
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19731 | Film No.: 22766505
SIC: 2836 Biological Products, (No Diagnostic Substances)